Vitamin D Supplementation for Bipolar Depression
Recruiting in Palo Alto (17 mi)
+1 other location
WM
Overseen byWendy Marsh, MD MSc
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Massachusetts, Worcester
Trial Summary
What is the purpose of this trial?
The purpose of this study is to whether vitamin d supplementation in those with low levels may reduce depression symptoms in people experiencing bipolar depression.
Research Team
WM
Wendy Marsh, MD MSc
Principal Investigator
University of Massachusetts, Worcester
Eligibility Criteria
Inclusion Criteria
Adults >18years old
Bipolar disorder (I,II or NOS)
MADRS Score>7 (mild)
See 2 more
Treatment Details
Interventions
- Placebo (Other)
- Vitamin D3, Cholecalciferol (Vitamin Supplement)
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Vitamin D3Experimental Treatment1 Intervention
Vitamin D3, Cholecalciferol, 5000IU po qday for 12 weeks
Group II: PlaceboPlacebo Group1 Intervention
methylcellulose po qday for 12weeks
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Massachusetts, Worcester
Lead Sponsor
Trials
372
Recruited
998,000+
Dr. Eric W. Dickson
University of Massachusetts, Worcester
Chief Executive Officer since 2013
MD from UMass Chan Medical School, Master's in Health Care Management from Harvard University
Dr. Andy Karson
University of Massachusetts, Worcester
Chief Medical Officer
MD